| Document |
Document Title |
|
WO/2023/182959A1 |
The present invention relates to a production method for stem cell culture and said cell culture, which can be used in autologous tissue engineering, congenital diseases, tumor growth inhibition, anticancer treatments, ischemic brain inj...
|
|
WO/2023/182581A1 |
The present application relates to: a method for producing retinol, comprising a step of culturing a Yarrowia sp. microorganism in a medium comprising an anti-oxidant; a method for increasing the production of retinol; a method for produ...
|
|
WO/2023/178849A1 |
The present invention relates to the field of biotechnology. Provided is an Escherichia coli strain for synthesizing L-valine, a method for constructing same, and use thereof. Provided is an Escherichia coli strain named as Escherichia c...
|
|
WO/2023/181068A1 |
The present invention relates to genetic modifications of microbes for increased nitrogen fixation which leads to the production of nitrogen containing primary metabolites, but not limited to Proteins, Enzymes, peptides, Phenolic compoun...
|
|
WO/2023/182244A1 |
The purpose of the present invention is to provide an antibody which inhibits the infection of cells with human norovirus (HuNoV) GII.2. More specifically, the present invention relates to a VHH antibody which binds to human norovirus (H...
|
|
WO/2023/182582A1 |
The present application relates to: a yarrowia microorganism having the ability to produce carotenoid, or a material having carotenoid as a precursor, the microorganism expressing Geranylgeranyl pyrophosphate synthase that is derived fro...
|
|
WO/2023/181067A1 |
The present invention provides genetic modification of microbes for improved Nitrogen fixation. More particularly, the present invention provides down regulation or deletion of glnA and amtB genes and over expression of nifA genes and gl...
|
|
WO/2023/181755A1 |
Provided is: a highly-safe and low-cost expression regulator for a factor particularly involved in maturation, moisture retention, or barrier function of the skin; an expression enhancer for an antimicrobial peptide; an expression enhanc...
|
|
WO/2023/182679A1 |
The present invention relates to a recombinant E. coli strain producing 1,3-butanediol from glucose and a method for producing 1,3-butanediol using same, in which a recombinant E. coli strain was developed in which a gene of a pathway ne...
|
|
WO/2023/179592A1 |
Provided is a recombinant fusion protein E35 specific to Mycobacterium tuberculosis, which comprises a protein ESAT6 and a protein PE35, and can sensitively and specifically detect Mycobacterium tuberculosis infections and can effectivel...
|
|
WO/2023/178439A1 |
A process to prepare an aqueous fertilizer with a high nitrogen content, said process comprising the steps of: - providing a solid material having a high nitrogen content; - providing a live yeast in solution adapted to enzymatically rem...
|
|
WO/2023/180925A1 |
Fermentation process for the production of lipids in the presence of at least one oleaginous yeast comprising: - a first step of growth of the oleaginous cell biomass wherein the respiratory quotient (RQ) of said at least one oleaginous ...
|
|
WO/2023/173899A1 |
Provided are Bacillus coagulans for ameliorating constipation and an application thereof. The strain is preserved in China General Microbiological Culture Collection Center on 10 November 2021, and has a preservation number of CGMCC No.2...
|
|
WO/2023/176849A1 |
Provided is a glucuronidase activator containing, as an active ingredient, Levilactobacillus brevis (Levilactobacillus brevis) strain I-3141 (accession number: CECT 7480).
|
|
WO/2023/175190A1 |
The invention relates to an automated process for extracting a peptide of interest located in periplasmic space and/or comprising an acidification step.
|
|
WO/2023/176835A1 |
The purpose of the present invention is to provide a xylose-inducible promoter having improved capability of promoting transcription of a downstream gene by modifying the base sequence of a xylose-inducible promoter (xylanase promoter) d...
|
|
WO/2023/177254A1 |
The present application provides: a microorganism with enhanced activity of aspartate 1-decarboxylase derived from Tribolium castaneum; a composition for producing beta-alanine and/or a beta-alanine-derived compound, the composition comp...
|
|
WO/2023/178194A2 |
Provided herein is a novel Akkermansia muciniphila strain. Compositions comprising the strain are also provided. Methods comprising administering the compositions to a subject in need thereof are also provided. In some embodiments, provi...
|
|
WO/2023/177160A1 |
The present application relates to an L-amino acid-producing microorganism having weakened carbamoyl phosphate synthase activity, and an L-amino acid production method using same.
|
|
WO/2023/177606A1 |
The subject invention provides compositions for treating standing water, such as retention ponds and puddles, as well as soils prone to flooding and pooling. More specifically, the subject invention provides microbe-derived compositions ...
|
|
WO/2023/177215A1 |
Provided are a Weissella cibaria strain having dental health enhancement activity and use thereof.
|
|
WO/2023/178211A1 |
Recombinant microbes comprising a novel pathway for producing fatty acid derivatives, such as fatty acid methyl esters, fatty acid ethyl esters, fatty alcohols, and fatty alcohol acetates, while generating low levels of 3-hydroxy fatty a...
|
|
WO/2023/175150A1 |
A process for preparing a microbial cell extract for food use is described, comprising mechanically disrupting cells (eg, yeast cell), and separating the disrupted cells into fractions. The fractions can be recombined and further process...
|
|
WO/2023/178197A1 |
Recombinant microbes comprising a novel pathway for producing trans-2 fatty acids and derivatives thereof are provided herein. The recombinant microbes comprise (1) either a combination of a 3-hydroxy acyl-ACP thioesterase and an acyl-Co...
|
|
WO/2023/177218A1 |
A Lacticaseibacillus paracasei strain having periodontal pathogen inhibitory activity, and use thereof are provided.
|
|
WO/2023/177208A1 |
The present invention relates to a method for preparing lactic acid bacterium-derived extracellular vesicles with improved yield. The inventors of the present invention have identified the optimal medium composition and fermentation cond...
|
|
WO/2023/177618A1 |
The present invention relates to an antimicrobial composition and probiotics against bacterial and fungal pathogens of fish. In particular, the invention pertains to a novel strain of the bacterial species Pseudomonas chlororaphis subsp....
|
|
WO/2023/176952A1 |
The purpose of the present invention is to provide a means for controlling the proliferation of a bacterium in the intestine. Provided is a composition for controlling the proliferation of any one bacterium selected from the group consis...
|
|
WO/2023/176951A1 |
Provided is a means for controlling proliferation of Collinsella bacteria in the intestines. The present invention addresses the problem of providing a novel material that is capable of controlling proliferation of Collinsella bacteria. ...
|
|
WO/2023/176943A1 |
The purpose of the present invention is to provide a protein glutaminase having improved oxidation stability. A protein glutaminase comprising a polypeptide comprising an amino acid sequence in which at least one substitution among (A) s...
|
|
WO/2023/175141A1 |
The invention pertains to a method for reducing the viscosity of a fermentation broth, wherein the method comprises the step of mixing at least one compound selected from the group consisting of ascorbic acid, citric acid, lactic acid, f...
|
|
WO/2023/177161A1 |
The present application relates to a carbamoyl-phosphate synthetase large subunit variant, a polynucleotide for coding the variant, a microorganism comprising the variant or the polynucleotide, and an L-ornithine production method using ...
|
|
WO/2023/173735A1 |
The present invention relates to the field of water-retaining materials, and in particular, to a biological water-retaining material, and a preparation method therefor and the use thereof. In order to solve the problem in the prior art o...
|
|
WO/2023/173221A1 |
The present invention concerns new strains of cyanogenic bacteria, and more particularly alkali-tolerant Pseudomonas bacteria, that are useful to gold mining activities. These bacteria are useful to leach gold from any source including o...
|
|
WO/2023/173566A1 |
The present invention relates to saccharomyces cerevisiae for producing rubusoside and an application thereof. A rubusoside synthesis gene is expressed in a saccharomyces cerevisiae strain, and an ABC efflux pump is overexpressed; and th...
|
|
WO/2023/175620A1 |
The present disclosure provides marine-derived bacterium, consortium comprising the same and uses therefore for hydrolyzing carbohydrate.
|
|
WO/2023/173181A1 |
The subject of the present invention relates to the new strain Bifidobacterium longum ssp. longum 3/15, filed under No. NBIMCC 9085 with the National Bank for Industrial Microorganisms and Cell Cultures (NBIMCC) of the Republic of Bulgar...
|
|
WO/2023/176970A1 |
Provided is an α-amylase which shows an excellent starch decomposition activity at lower temperatures and also shows excellent stability at a low pH value and/or in the presence of a chelating agent. Provided is an α-amylase variant ...
|
|
WO/2023/175079A1 |
The present invention is in the technical field of synthetic biology, metabolic engineering and cell cultivation. The present invention relates to newly identified alpha-2, 6-sialyltransferases having alpha- 2,6-sialyltransferase activit...
|
|
WO/2023/173637A1 |
The present invention provides a Bifidobacterium animalis subsp. lactis strain BLa36 for relieving constipation, a method for culturing same, and use thereof. The Bifidobacterium animalis subsp. lactis strain BLa36 for relieving constipa...
|
|
WO/2023/173408A1 |
An apparatus and method for constructing a single-cell sequencing library in a microdroplet. The apparatus comprises a droplet generation chip, a droplet sorting chip, a droplet collection apparatus, and a droplet injection apparatus. A ...
|
|
WO/2023/142861A9 |
The present invention provides a method for constructing a threonine-producing engineered bacterium. According to the present invention, a 2-formyl-citrate synthase 1-inactivated strain (corynebacterium) is applied to the production of t...
|
|
WO/2023/173189A1 |
The invention relates to a process for producing and purifying fructooligosaccharides (FOS) and to the product obtained by said process having a low glucose, fructose or saccharose residue content or none at all, FOS having a different p...
|
|
WO/2023/173565A1 |
Provided is a method for simultaneously enhancing and inhibiting multiple key genes during synthesis of 7-dehydrocholesterol in Saccharomyces cerevisiae by means of a dCpf1-VP activation system and a dCas9-RD inhibition system. In order ...
|
|
WO/2023/176950A1 |
Provided is a means for controlling the proliferation of any one bacterium selected from the group consisting of a bacterium belonging to the genus Faecalibacterium, a bacterium belonging to the genus Akkermansia, a bacterium belonging t...
|
|
WO/2023/177371A1 |
The invention relates to obtaining bacterial cellulose from the vinegar isolate Komagataeibacter sp GUS3, which produces 1.644 ±0,4016 g/L cellulose.
|
|
WO/2023/175124A1 |
The invention relates to a bacterium deficient in at least two functional genes in the redox pathway; or at least one functional gene in the vitamin B1 synthetic pathway and at least one functional gene in the vitamin B6 pathway. The inv...
|
|
WO/2023/171857A1 |
The present invention relates to a glycogen operon expression cassette comprising a maltose promoter. According to a method for producing an expression cassette, a transformed prokaryotic host cell, and glycogen, according to one aspect,...
|
|
WO/2023/169200A1 |
Provided are a recombinant yeast for producing lacto-N-triose, and an application thereof. The recombinant yeast comprises an amino acid sequence of a β-N-acetylglucosaminyl transferase and a coding nucleic acid sequence thereof, and/or...
|
|
WO/2023/171778A1 |
The purpose of the present invention is to provide a protein glutaminase in which a decrease in reactivity due to a high temperature is suppressed. This protein glutaminase is formed of a polypeptide having an amino acid sequence obtaine...
|
